Project Grant F32AI186362
Award Date
1/12/25
Completion Date
7/14/26
Dollars Obligated
$163K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to Yale University to conduct research focused on elucidating the cellular and molecular mechanisms governing IgE catabolism. The research aims to uncover the receptors and cell types responsible for IgE clearance, as well as the impact of IgE glycosylation on its catabolism. The project will employ...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 (Allergy and Infectious Diseases Research) provides $586,250.00 to the University of Massachusetts Medical School (UMass Medical) to conduct research on the generation and regulation of TFH13 cells that drive pathogenic IgE in allergic disease. The primary objectives of this 5-year research project are to: 1) determine the role of non-conventional antigen presenting cells...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $468,000.00 in funding to the University of Colorado-Denver to conduct research on the regulation and function of tissue-resident eosinophils, which play a key role in allergic and inflammatory diseases. The research aims to elucidate the mechanisms that enable eosinophil differentiation, survival, and specialized...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $162,000.00 to support research investigating the role of TGFβ signaling in regulating T follicular helper (Tfh) cell development and mast cell function in the context of allergic disease. The grant aims to clarify the complex, opposing effects of TGFβ on these key immune cell types and their relationship to...
This $2,151,847 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to investigate BACH1 as a master regulator of macrophage inflammatory response and differentiation. The central hypothesis is that BACH1 acts as a pioneering repressor and signal-dependent master regulator that plays a key role in controlling macrophage inflammatory gene expression, metabolism,...
This federal Project Grant award in the amount of $806,693.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at New York University School of Medicine to investigate the role of the lymphatic vasculature in regulating germinal center immune responses. The research aims to elucidate the mechanisms governing lymphangiogenesis during inflammation and determine how...
This federal Project Grant award, totaling $195,894, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function syndrome, a primary immune regulatory disorder. The research will be conducted at The Washington University in St. Louis and will involve immunophenotyping, transcriptional analysis, and in...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,483,910.00 to The Washington University to conduct research on novel genetic mechanisms underlying inborn errors of immunity (IEI) and primary immune regulation disorders (PIRD). The research aims to address significant gaps in the field, including the low molecular diagnostic rate for IEI and the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $722,958 in funding to the University of Rochester. The project aims to investigate the role of a novel monocyte-derived cell subset that produces galectin-1, a protein that enhances the formation and longevity of tissue-resident memory T cells in the respiratory tract. The research will (1) examine monocyte...
This Project Grant award, totaling $753,304.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to comprehensively define the molecular basis of IgE-mediated reactions to alpha-gal, the allergen associated with "alpha-gal syndrome" or red meat allergy. The research aims to expand a panel of naturally occurring human IgE monoclonal antibodies from...